Author

Ying Wang

Jiangsu Province HospitalORCID 0009-0001-9260-2062Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ying Wang39 papers · Chinese Academy of Sciences

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

Bing QiniD· 1 shared Hong-Jing Zhu· 1 shared Jia-Nan WangiD· 1 shared Jiang-Dong Ji· 1 shared Jin-Xiang Zhao· 1 shared Qing-Huai LiuiD· 1 shared Qun‐Dong SheniD· 1 shared Ru-Xu Sun· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Bing QinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell BiologyEMBO Molecular MedicinePeer-reviewedJan 31, 2024

Lactylation-driven FTO-mediated m6A modification of CDK2 aggravates diabetic microvascular anomalies

Xue Chen, Ying Wang, Jia-Nan Wang…·Qing-Huai Liu

This study shows that FTO, through lactylation-driven m6A modification of CDK2, worsens diabetic retinopathy by promoting angiogenesis and inflammation, and presents a nanotherapeutic approach to inhibit FTO.

154 citationstop 1%

𝕏 PostBluesky